0001437749-24-029040.txt : 20240912 0001437749-24-029040.hdr.sgml : 20240912 20240912135409 ACCESSION NUMBER: 0001437749-24-029040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240909 FILED AS OF DATE: 20240912 DATE AS OF CHANGE: 20240912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schoenberg Mark CENTRAL INDEX KEY: 0001763581 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 241294545 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA TA ASIYA STREET CITY: RA ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0508 4 2024-09-09 0001668243 UroGen Pharma Ltd. URGN 0001763581 Schoenberg Mark 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Medical Officer 0 Ordinary Shares 2024-09-09 4 M 0 1666 A 145950 D Ordinary Shares 2024-09-09 4 S 0 859 13.08 D 145091 D Restricted Stock Units 2024-09-09 4 M 0 1666 0 D Ordinary Shares 1666 3334 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. /s/ Jason D. Smith, Attorney-in-Fact 2024-09-12